You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

You are here

Information and Instructions for Submitting an Abstract

Definition of Categories

Clinical Vignette Competition
Definition: A clinical vignette is a report of one or more cases that illustrates a new disease entity, or a prominent or unusual clinical feature of an established disease. It may include a summary of pertinent patient history, physical findings, laboratory data, or management description.

Research Competition
Definition: Submissions can report clinical and/or laboratory-based research, delineate a new investigation into mechanisms of disease, or consist of detailed review of a clinical problem. Abstracts concerned with efficiency, cost or method of health care delivery, quality of care, and medical decision-making are also encouraged.

Abstract Eligibility

Original abstracts that either have or have not been presented at other meetings will be considered. Presentation of original work at the chapter meeting may, however, jeopardize presentation before another society. Abstracts are eligible if they have been published; however, abstracts based upon full papers that have been published are not eligible.

Author Eligibility

The first author of an abstract must be an ACP Associate in good standing.

Co-authors need not be ACP members. Abstracts must be signed by your Program Director.

You are encouraged to write your abstract in a format similar to that used in scientific papers so that it may be cited in curriculum vitae or submitted as evidence of scholarly activity when your are preparing to advance to Fellowship in the American College of Physicians.


  1. Abstracts must be typed on the official abstract form, single spaced within the border using a 10 point font, 450 word limit.
  2. Title, typed in all caps, should be brief and clearly state content of paper.
  3. Presenting author must list name first.
  4. List name and one degree only (e.g., MD, DO) for each author. Indicate status within ACP (Associate, Member, or Fellow), if applicable. Professional title of positions should not be included.
  5. List names of authors' institution(s), city, and state.

Note: The format used in the Annals of Internal Medicine is also encouraged.

The body of the abstract should be organized as follows:

  1. Purpose for study (one sentence if possible).
  2. Simple statement of methods.
  3. Summary of results (adequate to support conclusions).
  4. Statement of conclusions (Do not use phrases such as "The results will be discussed.")
  5. This format may be modified, as appropriate, for Clinical Vignette submissions, or for Research submissions diverging from the standard research methods.


Write for clarity and directness. Avoid the use of medical jargon or stock empty phrases. A table may be used if its fits within the border lines. Keep in mind that grammar will be taken into consideration. Please proofread your abstract carefully.

Abbreviations, Symbols, and Nomenclature

Usage should conform as closely as possible to that recommended in CBE Style Manual, (6th edition., 1994), published by the Council of Biology Editors, and available from CBE Secretariat, 9650 Rockville Pike, Bethesda, MD 20814. Nonstandard abbreviations must be kept to a minimum and must be explained when used. Generic names of drugs are preferred: a proprietary name may be given only with the first use of the generic name.

Units of measurement should be metric (SI), including those for height of length, mass (weight), and body temperature. Preferred concentration units in clinical chemical measurements are those recommended by the International Union of Pure and Applied Chemistry: for substances of known, pure composition, millimoles/milliliter or millimoles/liter; for mixtures of substances where exact composition is not known, grams/liter.